US Molecular Diagnostics Market 2023: Shares and Sales Forecasts by Test and Application
This report provides an overview of the US molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Contains 42 pages and 5 tables
Contains 42 pages and 5 tables
BUSINESS ENVIRONMENT
1. Health Care Expenditures
2. Cost Consciousness
3. Reimbursement
4. Industry Consolidation
5. Managed Care
a. PPO
b. HMO
6. Hospitals
7. Admissions
8. Length of Stay
9. Industry Diversification
10. Physician Demographics
11. Population Aging
a. Chronic Illness
b. Disease Incidence
c. Susceptibility to Iatrogenesis
d. Multiple Illness Cases
12. Laboratory Regulations
13. FDA Reform
MARKET STRUCTURE
1. Hospitals
2. Commercial/Private Laboratories
3. Blood Banks
MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ MARKET SHARES
1. Health Care Expenditures
2. Cost Consciousness
3. Reimbursement
4. Industry Consolidation
5. Managed Care
a. PPO
b. HMO
6. Hospitals
7. Admissions
8. Length of Stay
9. Industry Diversification
10. Physician Demographics
11. Population Aging
a. Chronic Illness
b. Disease Incidence
c. Susceptibility to Iatrogenesis
d. Multiple Illness Cases
12. Laboratory Regulations
13. FDA Reform
MARKET STRUCTURE
1. Hospitals
2. Commercial/Private Laboratories
3. Blood Banks
MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ MARKET SHARES
LIST OF TABLES
Molecular Diagnostics Test Volume Forecasts by Application
Molecular Diagnostic Sales Forecasts by Application
Market Share of Major Supplier of Molecular Diagnostic Tests
Market Shares of Major Supplier of HIV/Hepatitis Blood Screening Assays
Market Share of Major Supplier of West Nile Virus Blood Screening Assays
Molecular Diagnostics Test Volume Forecasts by Application
Molecular Diagnostic Sales Forecasts by Application
Market Share of Major Supplier of Molecular Diagnostic Tests
Market Shares of Major Supplier of HIV/Hepatitis Blood Screening Assays
Market Share of Major Supplier of West Nile Virus Blood Screening Assays
More Publications
2016 U.S. Hematology and Flow Cytometry Testing in Hospitals, Commercial Labs and Point-of-Care/POC Locations
US$ 9,200.00
November 2015
306 pages
US Hospital Hematology and Flow Cytometry Analyzers and Reagents, 2019-2023: Market Shares and Strategies, Segmentation Forecasts, Innovative Technologies, Latest Instrumentation
US$ 3,500.00
July 2019
248 pages
2013 Analysis of the US Hematology and Flow Cytometry Markets: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
US$ 7,880.00
April 2013
275 pages
2017-2021 US Hospital Tumor Marker Testing Market Forecasts: Supplier Shares by Test, Competitive Strategies, Innovative Technologies, Instrumentation Review
US$ 5,850.00
March 2017
567 pages
US Enteric Diseases: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia-Supplier Shares, Market Segment Forecasts, Competitive Strategies, Technology and Instrumentation Review, Emerging Opportunities
US$ 3,500.00
October 2019
322 pages
